Diltiazem Hydrochloride 100 mg / 1 Injection 10 Vial, Patent Delivery System
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 00409-4350-03 |
|---|---|
| Product NDC | 00409-4350 |
| Generic Drug Name | Diltiazem Hydrochloride |
| Brand Name | Diltiazem Hydrochloride |
| Manufacturer | Hospira, Inc. |
| Strength | 100 mg / 1 |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 10 Vial, Patent Delivery System |
| Package Description | 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4350-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-4350-13) |
| Active Ingredients | Diltiazem Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Diltiazem Hydrochloride 100 mg / 1 Injection is tracked under NDC 00409-4350-03 and rolls up into product family 00409-4350. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 10 Vial, Patent Delivery System.
- Manufacturer: Hospira, Inc..
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Documented shortage history shows this NDC appearing in shortage-related listings in 2015 and again in 2025, suggesting elevated future supply risk.
Drug Shortage Index family
View Diltiazem hydrochloride in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Diltiazem hydrochloride.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Diltiazem Hydrochloride 100 mg / 1 Injection 10 Vial, Patent Delivery System, NDC 00409-4350-03, is a Hospira, Inc. 100 mg / 1 injection presentation packaged as 10 Vial, Patent Delivery System. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 00409-4350-03
- Digits-only NDC 11: 00409435003
- Possible 10-digit display formats: 0409-4350-03 (0409435003), 00409-4350-3 (0040943503)
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Diltiazem Hydrochloride
- NDC 11: 00409-4350-03
- Product family NDC: 00409-4350
- VA classification code: CV200
- VA classification code description: CALCIUM CHANNEL BLOCKERS
- CMOP ID: D0408
- VUID: 4006691